New contact lenses aim to tame nearsightedness in children

NCT ID NCT05634408

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tested ACUVUE Abiliti 1-Day soft contact lenses designed to manage nearsightedness (myopia) in children. Over 1 to 2 years, researchers measured changes in eye length and vision in 75 participants. The goal was to see if these daily-use lenses can safely slow the worsening of nearsightedness.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
ACUVUE Abiliti 1-Day soft therapeutic contact lenses
What this could lead to
If successful, these lenses could help slow the progression of nearsightedness in children, reducing the need for stronger prescriptions over time.
What could go wrong
This is a small, single-site study with no comparison group, so results may not apply broadly. Contact lenses also carry risks like eye infections or discomfort.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for MYOPIA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hainan Boao Lecheng AIER Eye Hospital Co. LTD

    Qionghai, Hainan, 571400, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.